Validation of 1-year predictive score of long-term response to interferon-β in everyday clinical practice multiple sclerosis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of 1-year predictive score of long-term response to interferon-β in everyday clinical practice multiple sclerosis patients

Published:2015-04-06 Issue:6 Volume:22 Page:973-980
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Romeo M.¹,Martinelli V.¹,Rodegher M.¹,Perego E.¹,Maida S.¹,Sormani M. P.²,Comi G.¹³,

Affiliation:

1. Division of Neuroscience; Department of Neurology; Institute of Experimental Neurology (INSPE); San Raffaele Scientific Institute; Milan Italy

2. Department of Health Sciences; University of Genoa; Genoa Italy

3. Vita-Salute San Raffaele University; Milan Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12695/fullpdf

Reference20 articles.

1. Interferon beta-1b is effective in relapsing−remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial;The IFNB Multiple Sclerosis Study Group;Neurology,1993

2. Intramuscular interferon β-1a for disease progression in relapsing−remitting multiple sclerosis;Jacobs;Ann Neurol,1996

3. Randomised double-blind placebo controlled study of interferon β-1a in relapsing−remitting multiple sclerosis;PRIMS Study Group;Lancet,1998

4. Defining the response to interferon beta in relapsing-remitting multiple sclerosis patients;Rio;Ann Neurol,2006

5. Response to interferon-beta therapy in relapsing−remitting multiple sclerosis: a comparison of different clinical criteria;Portaccio;Mult Scler,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs;Multiple Sclerosis Journal;2024-03-29

2. Disease-modifying therapies;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

3. Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients;Journal of Neurology;2021-10-01

4. The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study;Acta Neurologica Belgica;2020-08-31

5. Predictive medicine in multiple sclerosis: A systematic review;Multiple Sclerosis and Related Disorders;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3